# Caladan Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caladan-bio

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.caladan.bio
- Total disclosed funding: $5.1M
- Latest round: Seed (Feb 2, 2024)
- Investors on record: 6

## About

Based in New York, US, and founded in 2023 by CEO Michael Kobida and Rob Jauquet, Caladan Bio Inc. operates as a biotech company that specializes in next-generation bioreactors to offer modular, affordable, and cutting-edge solutions. In February 2024, Caladan Bio Inc. raised USD 5.11 million in venture funding.

The company develops next-generation bioreactors for providing healthcare solutions.

## Funding rounds

- Seed, Feb 2, 2024, $5.1M — Lerer Hippeau Ventures, Collaborative Fund, Factorial Management, Wireframe Ventures, Twelve Below, Ritual Capital

## Investors

- Lerer Hippeau Ventures — Seed
- Collaborative Fund (https://capitalatlas.ai/funds/collaborative-fund) — Seed
- Factorial Management — Seed
- Wireframe Ventures (https://capitalatlas.ai/funds/wireframe-ventures) — Seed
- Twelve Below (https://capitalatlas.ai/funds/twelve-below) — Seed
- Ritual Capital (https://capitalatlas.ai/funds/ritual-capital) — Seed